AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Definitive Healthcare to Present at Morgan Stanley Healthcare Conference on September 9.
ByAinvest
Tuesday, Sep 2, 2025 4:08 pm ET1min read
Definitive Healthcare, a healthcare commercial intelligence firm, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025. CEO Kevin Coop and CFO Casey Heller will discuss the company's performance and strategy. The presentation will be available as a live webcast on Definitive Healthcare's investor relations website.
Definitive Healthcare (NASDAQ: DH), a leading healthcare commercial intelligence company, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's CEO, Kevin Coop, and CFO, Casey Heller, will deliver a presentation on Tuesday, September 9, 2025, at 9:15 a.m. ET. Investors can access a live webcast of the presentation through the Events section of Definitive Healthcare's investor relations website at ir.definitivehc.com. A replay will be available for a limited time after the event.The presentation will provide insights into Definitive Healthcare's performance and strategic direction. The company's platform offers actionable healthcare commercial data, empowering strategic decisions across the $4 trillion U.S. healthcare sector. Definitive Healthcare's participation in the conference is a significant opportunity for investors and industry professionals to gain a deeper understanding of the company's operations and future plans.
For more information, visit Definitive Healthcare's investor relations website at [1] https://www.definitivehc.com/.
References:
[1] https://www.definitivehc.com/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet